CentoScreen®: What you need to know about expanded carrier screening
Professor Peter Bauer, CSO of CENTOGENE, received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Moreover, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics and sequencing technology and is Senior author of the ‘Guidelines for diagnostic next-generation sequencing’ (Eur. J. Hum. Genet. 2016).
CentoWebinar - CentoScreen®: What you need to know about expanded carrier screening
Are you interested in learning more about carrier screening and how to apply it in your practice?
CentoScreen® provides a comprehensive and flexible panel analysis of 331 autosomal and X-linked recessive disorders that helps healthy couples determine their risk of having children with severe genetic diseases. Discover how cutting edge NGS technology and a comprehensive test design provides higher diagnostic accuracy.
- Definition and scope of carrier screening
- Technical design, workflow, and validation
- Interpretation and reporting of results
- Clinical implementation